FDA Inspection 1310608 — Nandita J. Jones, MD

Nandita J. Jones, MD — FEI 3014695669

The FDA completed an inspection of Nandita J. Jones, MD on March 27, 2026 in Jacksonville, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 27, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Jacksonville, FL (United States)

Additional Details

Clinical Investigator (CI)